202850-01-9 N-[12-[(7-Nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-ceramide C12-NBD Ceramide N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]-12-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]dodecanamide CHEBI:143826 CAS 202850-01-9

Purity 97%+In StockPharmaceutical Standards
CAS No.202850-01-9
Molecular FormulaC36H61N5O6
Molecular Weight659.90 g/mol
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

202850-01-9
N-[12-[(7-Nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-ceramide
C12-NBD Ceramide
N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]-12-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]dodecanamide
CHEBI:143826 CAS 202850-01-9 chemical structure

Description

202850-01-9 N-[12-[(7-Nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-ceramide C12-NBD Ceramide N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]-12-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]dodecanamide CHEBI:143826 (CAS 202850-01-9) is a high-purity pharmaceutical standards reference standard from CATO, an ISO 17034 accredited reference material producer. Molecular formula: C36H61N5O6. Molecular weight: 659.90 g/mol. Each batch is supplied with a Certificate of Analysis (COA).

Physical & Chemical Properties

Molecular FormulaC36H61N5O6
Molecular Weight659.90 g/mol
Purity97%+
StorageStore in a cool place (≤25°C), protect from light, keep sealed and dry
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)9.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)2014
Nitrogen Atoms5

Related N Standards

Recommended Standards

Why CATO?